newsfilter
← Latest News
GlobeNewswire·

Sandoz inaugurates new antibiotic production plant in Austria and new biosimilar development center in Germany

Investment of EUR 175 million reaffirms Sandoz commitment to long-term leadership in off-patent medicinesNew penicillin production process will significantly improve ecological footprint and help secure European-based